Exploration of Neuroprotective Therapy

Open Access Meta-Analysis

Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis

Shafiq Dexter B. Abou Zaki, Johnny K. Lokin

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:398–408

DOI: https://doi.org/10.37349/ent.2023.00057

This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke

Full Text PDF

9332 73 2

Open Access Review

Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy

Niklas Frank ... Carola Y. Förster

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:363–397

DOI: https://doi.org/10.37349/ent.2023.00056

This article belongs to the special issue Intervention of Neuroimmune Responses

Full Text PDF

14508 99 7

Open Access Review

Stem cell therapy in neurological disorders: promises and concerns

Said Hachimi-Idrissi

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:346–362

DOI: https://doi.org/10.37349/ent.2023.00055

This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke

Full Text PDF

11504 123 6

Open Access Review

Neuroprotective astroglial response to neural damage and its relevance to affective disorders

José Javier Miguel-Hidalgo

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:328–345

DOI: https://doi.org/10.37349/ent.2023.00054

Full Text PDF

4121 31 7

Open Access Original Article

Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease

Bianca Vlcek ... Åsa Wallén-Mackenzie

Published: October 30, 2023 Explor Neuroprot Ther. 2023;3:299–327

DOI: https://doi.org/10.37349/ent.2023.00053

Full Text PDF

5408 58 0

Open Access Review

The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson’s disease

Zaina Khan, Yoo Jin Jung

Published: October 26, 2023 Explor Neuroprot Ther. 2023;3:281–298

DOI: https://doi.org/10.37349/ent.2023.00052

Full Text PDF

6292 74 6

Open Access Original Article

Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit

Ana Isabel De Santiago-Díaz ... Elsa Gómez-Ruiz

Published: October 26, 2023 Explor Neuroprot Ther. 2023;3:268–280

DOI: https://doi.org/10.37349/ent.2023.00051

Full Text PDF

3248 30 0

Open Access Original Article

Cannabinoid CB₂ receptor ligands disrupt the sequential regulation of p-MEK1/2 to p-ERK1/2 in mouse brain cortex

Glòria Salort ... Jesús A. García-Sevilla

Published: October 24, 2023 Explor Neuroprot Ther. 2023;3:258–267

DOI: https://doi.org/10.37349/ent.2023.00050

This article belongs to the special issue The Urgent Need for New Hypotheses to Develop Effective Therapeutic Tools Against Alzheimer's Disease

Full Text PDF

2868 38 1